Abstract: A tent shelter with apex poles proportionally displaced relative to a rectangular footprint and faceted, pole-supported sidewalls is disclosed. An example embodiment includes: a tent canopy having an outer perimeter defining a generally rectangular footprint, the tent canopy configured with corners at the outer perimeter for removable fastening of the tent canopy outer perimeter to a ground surface with no more than four stakes; two apex poles, the tent canopy having two main canopy peaks configured to receive tips of the two apex poles removably insertable therein, the two main canopy peaks and the two apex poles being displaced in a longitudinal displacement relative to the corners of the tent canopy outer perimeter; and two secondary support poles, the tent canopy also having two secondary canopy peaks configured with two secondary support poles erectable therein, the two secondary support poles configured to create oblique pyramids in faceted sidewalls of the tent canopy.

Abstract: Systems and methods are provided for a power distribution device having a power input and a plurality of power receptacles. The power receptacles are coupled in parallel with each other. A switching circuit is coupled between the power input and the power receptacles. A circuit breaker detects when an aggregate current load of the receptacles is greater than a rating of the circuit breaker. The circuit breaker disconnects the power input from all of the receptacles after a first amount of time following the detection. An electronic controller is configured to disconnect a subset of the receptacles from the power input with the switching circuit to reduce the aggregate current load below the rating of the circuit breaker within a second amount of time following the detection. The second amount of time is less than the first amount of time.

Abstract: Disclosed are nucleic acid, RNA, and protein expression profiles which are indicative of the onset, predisposition to the onset and/or progression of a large intestine neoplasm. More particularly disclosed are nucleic acid molecules, the expression profiles of which are indicative of the onset and/or progression of a colorectal neoplasm, such as an adenoma or an adenocarcinoma. The expression profiles of the present invention are useful in a range of applications including, but not limited to, those relating to the diagnosis and/or monitoring of colorectal neoplasms, such as colorectal adenomas and adenocarcinomas. Further disclosed are methods of screening a subject for the onset, predisposition to the onset and/or progression of a large intestine neoplasm by screening for modulation in the expression profile of the disclosed nucleic acid molecule markers.

Abstract: The present invention relates generally to nucleic acid molecules in respect of which changes to the DNA or to the RNA or protein expression profiles are indicative of the onset, predisposition to the onset and/or progression of a neoplasm. More particularly, the present invention is directed to nucleic acid molecules in respect of which changes to the DNA or to the RNA or protein expression profiles are indicative of the onset and/or progression of a large intestine neoplasm, such as a adenoma or an adeocarcinoma. The DNA or the expression profiles of the present invention are useful in a range of applications including, but not limited to, those relating to the diagnosis and/or monitoring of colorectal neoplasms, such as colorectal adenocarcinoma.

Abstract: The present invention relates generally to nucleic acid molecules, the RNA and protein expression profiles of which are indicative of the onset, predisposition to the onset and/or progression of a neoplasm. More particularly, the present invention is directed to nucleic acid molecules, the expression profiles of which are indicative of the onset and/or progression of a large intestine neoplasm, such as an adenoma or an adenocarcinoma. The expression profiles of the present invention are useful in a range of applications including, but not limited to, those relating to the diagnosis and/or monitoring of colorectal neoplasms, such as colorectal adenocarcinomas. Accordingly, in a related aspect the present invention is directed to a method of screening a subject for the onset, predisposition to the onset and/or progression of a neoplasm by screening for modulation in the expression profile of one or more nucleic acid molecule markers.

Abstract: The present invention relates generally to an array of nucleic acid molecules, the expression profiles of which characterise the anatomical origin of a cell or population of cells within the large intestine. More particularly, the present invention relates to an array of nucleic acid molecules, the expression profiles of which characterise the proximal or distal origin of a cell or population of cells within the large intestine. The expression profiles of the present invention are useful in a range of applications including, but not limited to determining the anatomical origin of a cell or population of cells which have been derived from the large intestine.

Abstract: The present invention relates generally to nucleic acid molecules, the RNA and protein expression profiles of which are indicative of the onset, predisposition to the onset and/or progression of a neoplasm. More particularly, the present invention is directed to nucleic acid molecules, the expression profiles of which are indicative of the onset and/or progression of a large intestine neoplasm, such as an adenoma or an adenocarcinoma. The expression profiles of the present invention are useful in a range of applications including, but not limited to, those relating to the diagnosis and/or monitoring of colorectal neoplasms, such as colorectal adenocarcinomas. Accordingly, in a related aspect the present invention is directed to a method of screening a subject for the onset, predisposition to the onset and/or progression of a neoplasm by screening for modulation in the expression profile of one or more nucleic acid molecule markers.

Abstract: A system for fragmenting material includes an energy source, an acoustic transmitter, and a controller. The acoustic transmitter is coupled to the energy source and includes a unit acoustic source configured to emit an acoustic wave through a volume of ground material. The controller is coupled to the acoustic transmitter and is configured to engage the unit acoustic source such that the acoustic wave fractures the volume of ground material at a target location.

Abstract: The present invention relates generally to a nucleic acid molecule, the RNA and protein expression profiles of which are indicative of the onset, predisposition to the onset and/or progression of a large intestine neoplasm. More particularly, the present invention is directed to a nucleic acid molecule, the expression profiles of which are indicative of the onset and/or progression of a colorectal neoplasm, such as an adenoma or an adenocarcinoma. The expression profiles of the present invention are useful in a range of applications including, but not limited to, those relating to the diagnosis and/or monitoring of colorectal neoplasms, such as colorectal adenomas and adenocarcinomas. Accordingly, in a related aspect the present invention is directed to a method of screening a subject for the onset, predisposition to the onset and/or progression of a large intestine neoplasm by screening for modulation in the expression profile of said nucleic acid molecule markers.

Abstract: A system for fragmenting material includes an energy source, an acoustic transmitter, and a controller. The acoustic transmitter is coupled to the energy source and includes a unit acoustic source configured to emit an acoustic wave through a volume of ground material. The controller is coupled to the acoustic transmitter and is configured to engage the unit acoustic source such that the acoustic wave fractures the volume of ground material at a target location.

Abstract: The present invention relates generally to nucleic acid molecules, the RNA and protein expression profiles of which are indicative of the onset, predisposition to the onset and/or progression of a neoplasm. More particularly, the present invention is directed to nucleic acid molecules, the expression profiles of which are indicative of the onset and/or progression of a large intestine neoplasm, such as an adenoma or an adenocarcinoma. The expression profiles of the present invention are useful in a range of applications including, but not limited to, those relating to the diagnosis and/or monitoring of colorectal neoplasms, such as colorectal adenocarcinomas. Accordingly, in a related aspect the present invention is directed to a method of screening a subject for the onset, predisposition to the onset and/or progression of a neoplasm by screening for modulation in the expression profile of one or more nucleic acid molecule markers.

Abstract: The present invention relates generally to nucleic acid molecules in respect of which changes to the DNA or to the RNA or protein expression profiles are indicative of the onset, predisposition to the onset and/or progression of a neoplasm. More particularly, the present invention is directed to nucleic acid molecules in respect of which changes to the DNA or to the RNA or protein expression profiles are indicative of the onset and/or progression of a large intestine neoplasm, such as an adenoma or an adenocarcinoma. The DNA or the expression profiles of the present invention are useful in a range of applications including, but not limited to, those relating to the diagnosis and/or monitoring of colorectal neoplasms, such as colorectal adenocarcinomas.

Abstract: A system for assaying gold in a rock formation includes a transmitter and an acoustic sensor. The transmitter is configured to transmit a microwave pulse into the rock formation. The acoustic sensor is coupled to the rock formation and is configured to detect an acoustic wave emitted from the rock formation in response to receipt by the rock formation of the microwave pulse.

Abstract: The present invention relates generally to a nucleic acid molecule, the RNA and protein expression profiles of which are indicative of the onset, predisposition to the onset and/or progression of a large intestine neoplasm. More particularly, the present invention is directed to a nucleic acid molecule, the expression profiles of which are indicative of the onset and/or progression of a colorectal neoplasm, such as an adenoma or an adenocarcinoma. The expression profiles of the present invention are useful in a range of applications including, but not limited to, those relating to the diagnosis and/or monitoring of colorectal neoplasms, such as colorectal adenomas and adenocarcinomas. Accordingly, in a related aspect the present invention is directed to a method of screening a subject for the onset, predisposition to the onset and/or progression of a large intestine neoplasm by screening for modulation in the expression profile of said nucleic acid molecule markers.

Abstract: The present invention relates generally to nucleic acid molecules in respect of which changes to the DNA or to the RNA or protein expression profiles are indicative of the onset, predisposition to the onset and/or progression of a neoplasm. More particularly, the present invention is directed to nucleic acid molecules in respect of which changes to the DNA or to the RNA or protein expression profiles are indicative of the onset and/or progression of a large intestine neoplasm, such as an adenoma or an adenocarcinoma. The DNA or the expression profiles of the present invention are useful in a range of applications including, but not limited to, those relating to the diagnosis and/or monitoring of colorectal neoplasms, such as colorectal adenocarcinomas.

Abstract: The present invention relates generally to nucleic acid molecules, the RNA and protein expression profiles of which are indicative of the onset, predisposition to the onset and/or progression of a neoplasm. More particularly, the present invention is directed to nucleic acid molecules, the expression profiles of which are indicative of the onset and/or progression of a large intestine neoplasm, such as an adenoma or an adenocarcinoma. The expression profiles of the present invention are useful in a range of applications including, but not limited to, those relating to the diagnosis and/or monitoring of colorectal neoplasms, such as colorectal adenocarcinomas. Accordingly, in a related aspect the present invention is directed to a method of screening a subject for the onset, predisposition to the onset and/or progression of a neoplasm by screening for modulation in the expression profile of one or more nucleic acid molecule markers.

Abstract: The present invention relates generally to an array of nucleic acid molecules, the expression profiles of which characterise the anatomical origin of a cell or population of cells within the large intestine. More particularly, the present invention relates to an array of nucleic acid molecules, the expression profiles of which characterise the proximal or distal origin of a cell or population of cells within the large intestine. The expression profiles of the present invention are useful in a range of applications including, but not limited to determining the anatomical origin of a cell or population of cells which have been derived from the large intestine.

Abstract: A method of identifying endmember spectral values from multispectral image data, where each multispectral data value is equal to a sum of mixing proportions of each endmember spectrum. The method comprises the steps of processing the data to obtain a multidimensional simplex having a number of vertices equal to the number of endmembers. The position of each vertex represents a spectrum of one of the endmembers. Processing the data is conducted by providing starting estimates of each endmember spectrum for each image data value. The mixing proportions for each data value is estimated from estimates of the spectra of all the endmembers. The spectrum of each endmember is estimated from estimates of the mixing proportions of the spectra of all the endmembers for each image data value. The estimation steps are repeated until a relative change in the regularised residual sum of squares is sufficiently small. The regularised residual sum of squares includes a term which is a measure of the size of the simplex.

Abstract: A method for identifying components of a system from data generated from the system, which exhibit a response pattern associated with a test condition applied to the system, comprising the steps of specifying design factors to specify a response pattern for the test condition and identifying a linear combination of components from the input data which correlate with the response pattern.

Abstract: The air inlet to the compressor of a gas turbine is supplied with liquid nitrogen for cooling the ambient inlet air. The heated nitrogen converts to gaseous nitrogen and is supplied to either the combustor to lower the flame temperature and hence reduce NO.sub.x formations within the combustor or the turbine section to increase mass flow and hence increase power output, or both. Liquid nitrogen is also supplied in heat exchange relation with the cooling system of a generator driven by the turbine section. The operating temperature of the generator is thus lowered, thereby increasing its capacity and power. The nitrogen from the heat exchanger of the generator cooling system converts to gaseous nitrogen and is supplied to the combustor for lowered NO.sub.x emissions or to the turbine for improved mass flow, or both.